Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-16

FDA Approved: ABACAVIR — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for abacavir sulfate by Rising Pharma Holdings, Inc. This action represents an additional regulatory approval for the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • abacavir (abacavir)

Snippet

SUPPL AP for ABACAVIR (ABACAVIR SULFATE)